ACE2 Is a Prognostic Biomarker and Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma: Implication for COVID-19

Table 1

Correlation of ACE2 expression and the overall survival of KIRC with different clinicopathological factors (Kaplan–Meier plotter).

Pathological parameters	Case number	Hazard radio	value
Stage status
1	398	0.57 (0.31–1.05)	0.069
2	184	0.29 (0.1–0.89)	0.021
3	332	0.34 (0.19–0.6)	0.00011
4	188	0.26 (0.15–0.45)	2.5e^−7
Gender
Female	284	0.41 (0.25–0.68)	0.00038
Male	948	0.35 (0.24–0.52)	2e^−8
White	690	0.36 (0.26–0.5)	3.2e^−11
Asian	8	NA	NA
Black/African-American	111	2.81 (0.59–13.37)	0.18
Tumor grade
1	14	NA	NA
2	340	0.5 (0.28–0.92)	0.022
3	585	0.38 (0.24–0.61)	2.2e^−5
4	174	0.42 (0.23–0.77)	0.0039
Mutation burden
high	246	0.43 (0.25–0.76)	0.0027
low	437	0.34 (0.16–0.75)	0.0051